Z Chen, AS Azman, X Chen, J Zou, Y Tian, R Sun… - Nature …, 2022 - nature.com
… our understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. We performed a global landscapeanalysis on SARS-CoV-2 genomic surveillance and …
… In our Analysis, different SARS-CoV-2 proteins harbor the maximum rate of mutations, including N, nsp3, S, nsp4, nsp12, and M. The rate of four mutations and above is depicted in Fig. …
… Some significant mutations (E484K, K417T/N, N501Y, and D614G) found in emerging variants and their structural landscapes. We performed structural landscapeanalysis of some …
L Martin-Sancho, MK Lewinski, L Pache, CA Stoneham… - Molecular cell, 2021 - cell.com
… -2) infection has been implicated as a determinant of severe coronavirus disease 2019 (… IFN control of SARS-CoV-2 infection, we conducted a large-scale gain-of-function analysis that …
D Wang, A Jiang, J Feng, G Li, D Guo, M Sajid, K Wu… - Molecular cell, 2021 - cell.com
… landscapes of SARS-CoV-2 subgenomes. Interestingly, template switching could occur in a bidirectional manner, with diverse SARS-CoV-2 … the subgenome landscape of SARS-CoV-2 …
B Saldivar-Espinoza, P Garcia-Segura… - International Journal of …, 2023 - mdpi.com
… analyze the mutational landscape of SARS-CoV-2 using data from more than 5 million SARS-CoV-… , and in particular, we analyze their distribution among SARS-CoV-2 genes, the most …
X Wang, G Xu, X Liu, Y Liu, S Zhang… - Cellular & Molecular …, 2021 - nature.com
… and dynamic subgenomic landscapes of SARS-CoV-2 [13]. N6… identified on the genomic RNA of SARS-CoV-2 through RNA … landscape and unreported regulatory regions of SARS-CoV-…
AS Heffron, SJ McIlwain, MF Amjadi, DA Baker… - PLoS …, 2021 - journals.plos.org
… analysis of antibody binding to the full proteome of SARS-CoV-2, the highest magnitude binding of anti-SARS-CoV-2 … to SARS-CoV M are similar to those we found in SARS-CoV-2 [35]. …
… virus during SARS-CoV-2 infection. We also summarize the mutations across the SARS-CoV-… resources for developing novel therapeutic strategies for combating SARS-CoV-2 infection. …